VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
about
Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.Role of Transient Receptor Potential Ankyrin 1 Ion Channel and Somatostatin sst4 Receptor in the Antinociceptive and Anti-inflammatory Effects of Sodium Polysulfide and Dimethyl Trisulfide.
P2860
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VPAC1 receptor (Vipr1)-deficie ...... eficits in the effector stage.
@en
VPAC1 receptor (Vipr1)-deficie ...... eficits in the effector stage.
@nl
type
label
VPAC1 receptor (Vipr1)-deficie ...... eficits in the effector stage.
@en
VPAC1 receptor (Vipr1)-deficie ...... eficits in the effector stage.
@nl
prefLabel
VPAC1 receptor (Vipr1)-deficie ...... eficits in the effector stage.
@en
VPAC1 receptor (Vipr1)-deficie ...... eficits in the effector stage.
@nl
P2093
P2860
P1476
VPAC1 receptor (Vipr1)-deficie ...... eficits in the effector stage.
@en
P2093
Bhavaani Jayaram
Catalina Abad
James A Waschek
Laurine Becquet
Yossan-Var Tan
P2860
P2888
P356
10.1186/S12974-016-0626-3
P577
2016-06-29T00:00:00Z
P6179
1041867781